GovChime
Notice ID: 3fca19a50da6422c9e851d530af91d68Solicitation

A--PREVENT IDIQ MATO RFP

Archived on March 15, 2023. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
10:00 AM UTC−05:00
Posted
September 16, 2024
Notice type
Solicitation
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NIH NCI
Last updated
Sep 9, 2025

Identifiers

Solicitation number
75N91023R00024
Notice ID
3fca19a50da6422c9e851d530af91d68

Description

Amendment 02 is to issue minor changes to solicitation, 75N91023R00024, for the PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers, Preclinical Services for Biopharmaceutical Product Development and Manufacturing, and Toxicology and Pharmacology Testing. See attached for additional details.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N91023R00024
  1. Pre-Solicitation
  2. Solicitation
  3. Awarded

Award typically follows within 30–90 days after the response deadline. (estimate)

  1. 2×
    Pre-SolicitationDec 19, 2022

    A--PREVENT IDIQ MATO RFP

    Notice 28cad30a765049f4b35ad06f1360ba4b on SAM.gov

  2. 3×
    SolicitationJan 6, 2023

    A--PREVENT IDIQ MATO RFP

    Notice d3cf76bbf0a94629b5f0f9c9fb4d553c on SAM.gov

  3. 4×
    AwardedFeb 1, 2024

    A--PREVENT Preclinical Efficacy & Endpoint Biomarkers

    Notice f642a53e12b7455f90ee6e1a063d04f3 on SAM.gov

  4. SolicitationCurrentSep 16, 2024

    A--PREVENT IDIQ MATO RFP

    Notice 3fca19a50da6422c9e851d530af91d68 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N91023R00024

Archive Date

Mar 15, 2023

Office Address

Bethesda, MD, 20892